国际标准期刊号: 2167-065X

临床药理学与生物药剂学

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • CAS 来源索引 (CASSI)
  • 哥白尼索引
  • 谷歌学术
  • 夏尔巴·罗密欧
  • Genamics 期刊搜索
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

Pharmaceutical Revolution Extends Beyond Drug Development

Sanna Bardaweel

The pharmaceutical industry has been at the forefront of transforming healthcare, revolutionizing the way diseases are treated and managed. Over the past few decades, scientific advancements have propelled the development of innovative drugs and therapies that have saved countless lives and improved the quality of life for millions of people worldwide. This article explores the key ways in which the pharmaceutical revolution has transformed healthcare through groundbreaking scientific discoveries and the development of new treatment modalities. Immunotherapies have emerged as a groundbreaking treatment approach in the fight against cancer and autoimmune diseases. These therapies harness the power of the body's immune system to recognize and eliminate cancer cells or target malfunctioning immune responses. Immune checkpoint inhibitors, CAR-T cell therapy, and therapeutic vaccines are some of the game-changing immunotherapies that have shown remarkable success in treating previously untreatable conditions.

免责声明: 此摘要通过人工智能工具翻译,尚未经过审核或验证。